Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve the Un-audited Financial Results for the quarter ended 30th June, 2025 and declaration of Interim Dividend for the FY25-26